137 related articles for article (PubMed ID: 15649714)
1. A comment on the CE marking of iliac artery stents.
Gaines PA
Eur J Vasc Endovasc Surg; 2005 Feb; 29(2):105. PubMed ID: 15649714
[No Abstract] [Full Text] [Related]
2. CE mark for iliac stents.
Croft RJ
Eur J Vasc Endovasc Surg; 2005 Oct; 30(4):451. PubMed ID: 16019240
[No Abstract] [Full Text] [Related]
3. US and European postmarket clinical data requirements.
Donawa M
Med Device Technol; 2005 Mar; 16(2):19-21. PubMed ID: 15828495
[TBL] [Abstract][Full Text] [Related]
4. The impact of the new quality management system standards on the CE-marking process.
Donawa M
Med Device Technol; 2001; 12(1):34-9. PubMed ID: 11317864
[TBL] [Abstract][Full Text] [Related]
5. U.S.-Sino safety pact called 'modest start'. Experts say more must be done to ensure safe drug, medical device imports.
Rhea S
Mod Healthc; 2007 Dec; 37(50):12-3. PubMed ID: 18200957
[No Abstract] [Full Text] [Related]
6. Vioxx, radiology, and the Food and Drug Administration.
Pentecost MJ
J Am Coll Radiol; 2005 May; 2(5):394-7. PubMed ID: 17411841
[No Abstract] [Full Text] [Related]
7. Beyond the US submisson process.
Donawa M
Med Device Technol; 2004 Apr; 15(3):30-2. PubMed ID: 15255536
[TBL] [Abstract][Full Text] [Related]
8. The evolving process of European combination product review, Part I.
Donawa ME
Med Device Technol; 2008 Oct; 19(6):32, 34-5. PubMed ID: 18988546
[TBL] [Abstract][Full Text] [Related]
9. The IVD directive: late-phase practicalities.
Johnson P; Walker R
Med Device Technol; 2003 Nov; 14(9):35-6. PubMed ID: 14682022
[No Abstract] [Full Text] [Related]
10. European GMO labeling thresholds impractical and unscientific.
Weighardt F
Nat Biotechnol; 2006 Jan; 24(1):23-5. PubMed ID: 16404384
[No Abstract] [Full Text] [Related]
11. New trends in biological evaluation of medical devices.
Bollen LS
Med Device Technol; 2005 Jun; 16(5):10-5. PubMed ID: 15984539
[TBL] [Abstract][Full Text] [Related]
12. Standardising graphical symbols.
Moore R
Med Device Technol; 2004 May; 15(4):31. PubMed ID: 15303562
[TBL] [Abstract][Full Text] [Related]
13. Identity tags.
Pauli U
Nat Biotechnol; 2003 Jun; 21(6):598. PubMed ID: 12776138
[No Abstract] [Full Text] [Related]
14. Identity tags revisited.
Marillonnet S; Klimyuk V; Gleba Y
Nat Biotechnol; 2003 Sep; 21(9):974-5; author reply 975. PubMed ID: 12949551
[No Abstract] [Full Text] [Related]
15. The essential element of ethics.
Donawa ME
Med Device Technol; 2004 Jun; 15(5):27-9. PubMed ID: 15285485
[TBL] [Abstract][Full Text] [Related]
16. Off-label use: an industry perspective on expanding use beyond approved indications.
Russell ME; Friedman MI; Mascioli SR; Stolz LE
J Interv Cardiol; 2006 Oct; 19(5):432-8. PubMed ID: 17020568
[TBL] [Abstract][Full Text] [Related]
17. Model for tuning GMO detection in seed and grain.
Macarthur R; Murray AW; Allnutt TR; Deppe C; Hird HJ; Kerins GM; Blackburn J; Brown J; Stones R; Hugo S
Nat Biotechnol; 2007 Feb; 25(2):169-70. PubMed ID: 17287745
[No Abstract] [Full Text] [Related]
18. Drug-eluting stents "deliver heartburn": how do we spell relief going forward?
Krucoff MW; Boam A; Schultz DG
Circulation; 2007 Jun; 115(23):2990-4. PubMed ID: 17473280
[No Abstract] [Full Text] [Related]
19. [Increased safety requirements concerning products of medical technology. New rules make CE labeling compulsory in most cases].
Liedström G
Lakartidningen; 1998 Aug; 95(35):3681-2. PubMed ID: 9748783
[No Abstract] [Full Text] [Related]
20. Encoding technical information in GM organisms.
Marillonnet S; Klimyuk V; Gleba Y
Nat Biotechnol; 2003 Mar; 21(3):224-6. PubMed ID: 12610560
[No Abstract] [Full Text] [Related]
[Next] [New Search]
